Cytek Biosciences, Inc. Quarterly Return On Equity in % from Q4 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cytek Biosciences, Inc. annual/quarterly Return On Equity history and growth rate from Q4 2020 to Q2 2023.
  • Cytek Biosciences, Inc. Return On Equity for the quarter ending June 30, 2023 was -1.39 %, a 116% decline year-over-year.
  • Cytek Biosciences, Inc. annual Return On Equity for 2023 was -2.93 %, a 590% decline from 2022.
  • Cytek Biosciences, Inc. annual Return On Equity for 2022 was 0.6 %, a 61.4% decline from 2021.
  • Cytek Biosciences, Inc. annual Return On Equity for 2021 was 1.55 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -1.39 -0.74 -116% Apr 1, 2023 Jun 30, 2023
Q1 2023 -0.52 -0.77 -302% Jan 1, 2023 Mar 31, 2023
Q4 2022 0.6 -0.95 -61.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -0.58 -11.4 -105% Jul 1, 2022 Sep 30, 2022
Q2 2022 -0.64 +85.6 +99.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 0.25 +88.3 Jan 1, 2022 Mar 31, 2022
Q4 2021 1.55 +66.1 Oct 1, 2021 Dec 31, 2021
Q3 2021 10.8 Jul 1, 2021 Sep 30, 2021
Q2 2021 -86.2 Apr 1, 2021 Jun 30, 2021
Q1 2021 -88 Jan 1, 2021 Mar 31, 2021
Q4 2020 -64.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.